For more information, or to register for this event, visit The Evolving Role of Ion Channels in Shaping Successful Drug Discovery. Join Dr Michael Morton, Director and Co-founder of ApconiX in a live webinar on Thursday, November 19th 2020 at 11am EST (4pm GMT). In this free webinar, hosted by Xtalks, attendees will learn [...]
Dr Laurence Bishop will be attending BioJapan online between 14th and the 16th of October 2020. BioJapan is being held at the Pacifico Yokohama in Japan this year and will be a hybrid of partnering taking place online and onsite. Some companies are exhibiting live and there will also be a mixture of live and [...]
ApconiX welcomes Dr Selvan Bavan, who joins us to carry out ion channel research using manual patch-clamp while learning more about using automated patch-clamp by working with Dr Michael Morton and Dr Karen Jones. Selvan commented, “Conventional manual patch-clamp is regarded as a ‘gold standard’ technique to record ion channel currents, but this technique has [...]
ApconiX welcomes Charlotte North to the team. Charlotte graduated from Sheffield University in July with a degree in Biomedical Sciences and is working in the ApconiX Ion Channel Laboratory as an industry placement student this month. Charlotte has been spending her time, since graduating, exploring the many opportunities the pharmaceutical industry can offer. She is [...]
It is wonderful to see the original publication of patch-clamp methodology included in Nature’s 10 extraordinary papers (published 22 October 2019). The ground-breaking work of Neher and Sakmann sits alongside the discovery of the structure of DNA, cell reprogramming and birth of nanomaterials. At this time, Neher and Sakmann had recruited a Post Doc called [...]
Read the poster Dr Kim Rockley and Dr Michael Morton presented at ELRIG 2019 in Liverpool.
ApconiX is delighted to be presenting a poster at ELRIG 2019 titled “Sodium channel selectivity of two anti-epileptic drugs.” The poster includes research started by our placement student Priscilla Dumenu. Dr Michael Morton, Dr Richard Knight, Dr Kimberly Rockley, Phumzile Sikakana and Olivia Turner are all attending the conference. “I am really looking forward to [...]
The hERG assay has been a mainstay of safety screening in drug discovery for the last 2 decades. Aided by the development of high throughput automated technology, this important assay has brought unparalleled progress in our ability to design safer drugs without those properties that may lead to life-threatening cardiac arrhythmia. In a series of [...]
ApconiX is delighted to welcome William O'Brien as their new Finance Director. William has a strong background in high-tech development management and corporate finance. William is the founder of WOCO, a specialist R&D tax and financial advisory business based at Alderley Park, Cheshire. A seasoned leader, he previously worked across a wide range of industries [...]
ApconiX has joined the Medicines Discovery Catapult’s Virtual R&D platform. This is a unique national network of consultants, private sector CROs, expert labs and public sector centres of excellence, providing medicines discovery expertise, services and virtual programme management. ApconiX specialises in ion channel biology, target safety assessments and in all aspects of nonclinical programme design [...]
